Presynaptic inactivation of action potentials and postsynaptic inhibition of GABAA currents contribute to KA-induced disinhibition in CA1 pyramidal neurons.
Kainate-type glutamate ionotropic receptors (KAR) mediate either depression or potentiation of inhibitory transmission. The mechanisms underlying the depressant effect of KAR agonists have been controversial. Under dual patch-clamp recording techniques in synaptically coupled pairs of CA1 interneurons and pyramidal neurons in hippocampal slices, micromolar concentrations of KAR agonists, kainic acid (KA, 10 microM) and ATPA (10 microM), induced inactivation of action potentials (APs) in 58 and 50% of presynaptic interneurons, respectively. Inactivation of interneuronal APs might have significantly contributed to KA-induced decreases in evoked inhibitory postsynaptic currents (eIPSCs) that are obtained by stimulating the stratum radiatum. With controlled interneuronal APs, KAR agonists induced a decrease in the potency (mean amplitude of successful events) and mean amplitude (including failures) of unitary inhibitory postsynaptic currents (uIPSCs) without significantly changing the success rate (P(s)) at perisomatic high-P(s) synapses. In contrast, KAR agonists induced a decrease in both the P(s) and potency of uIPSCs at dendritic high-P(s) synapses. KAR agonists induced an inhibition of GABA(A) currents by activating postsynaptic KARs in pyramidal neurons; this was more prominent at dendrites than at soma. Both the exogenous GABA-induced current and the amplitude of miniature IPSCs (mIPSCs) were attenuated by KAR agonists. Thus the postsynaptic KAR-mediated inhibition of GABA(A) currents may contribute to the KAR agonist-induced decrease in the potency of uIPSCs and KA-induced disinhibition.
Kang
Ning
N
Dept. of Cell Biology and Anatomy, New York Medical College, Basic Science Bldg., Rm. 220, Valhalla, NY 10595, USA.
Jiang
Li
L
He
Wei
W
Xu
Jun
J
Nedergaard
Maiken
M
Kang
Jian
J
D000200:Action Potentials / Q000187:drug effects / Q000502:physiology; D000818:Animals; D003712:Dendrites / Q000187:drug effects / Q000502:physiology; D004553:Electric Conductivity; D006624:Hippocampus / Q000166:cytology / Q000502:physiology*; D066298:In Vitro Techniques; D007395:Interneurons / Q000187:drug effects / Q000502:physiology; D007608:Kainic Acid / Q000494:pharmacology*; D009433:Neural Inhibition / Q000187:drug effects*; D018408:Patch-Clamp Techniques; D017729:Presynaptic Terminals / Q000502:physiology*; D017966:Pyramidal Cells / Q000502:physiology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D011963:Receptors, GABA-A / Q000187:drug effects / Q000502:physiology*; D018092:Kainic Acid Receptors / Q000819:agonists; D013569:Synapses / Q000187:drug effects / Q000502:physiology*
D007608:Kainic Acid; D011963:Receptors, GABA-A; D018092:Kainic Acid Receptors